Pakistani health authorities are implementing emergency measures to ensure the availability of pharmaceutical supplies following the suspension of trade with India. The Drug Regulatory Authority of Pakistan (DRAP) is actively seeking alternative sources in countries like China, Russia, and Europe for raw materials and essential medicines. The Pakistan Pharmaceutical Manufacturers Association (PPMA) has called on the government to exempt the pharmaceutical sector from the trade ban to prevent any potential shortages of critical life-saving drugs. This move comes in response to the recent Pahalgam terror attack in India, which led to the suspension of trade between the two countries. By diversifying their sources and advocating for sectoral exemptions, Pakistani health officials and industry stakeholders aim to safeguard the availability of vital medications for the population.